摘要
肝性脑病是终末期肝病发展过程中常见的一种代谢性神经精神异常综合征。自从肠-肝-脑轴的概念提出以来,对于肝性脑病发病过程与肠道菌群的关系一直是研究的热点。近年来肠道菌群越来越引起人们的重视,已有研究证实肠道菌群参与并影响了肝性脑病的多种病理环节。本文结合国内外的最新研究进展,针对调控肠道菌群进而干预肝性脑病病理进程的研究现状进行阐述,希望为基于肠道菌群调控干预肝性脑病进展提供新的思路与方法。
Hepatic encephalopathy is a common metabolic neuropsychiatric syndrome in the development of end-stage liver disease.Since the concept of intestinal-liver-brain axis was proposed,the relationship between the pathogenesis of hepatic encephalopathy and the gut microbiota has been a hot research topic.In recent years,studies have confirmed that gut microbiota is involved in and affects various pathological processes of hepatic encephalopathy.This article combines the latest research progress at home and abroad to elaborate on the research status of regulating gut microbiota and thus interfering with the pathological process of hepatic encephalopathy,hoping to provide new ideas and methods for the intervention of hepatic encephalopathy based on the regulation of gut microbiota.
作者
尹佳婷
彭印
徐文浩
毛梦菲
段金廒
郭建明
YIN Jia-ting;PENG Yin;XU Wen-hao;MAO Meng-fei;DUAN Jin-ao;GUO Jian-ming(Jiangsu Key Laboratory of High Technology Research of TCM Formulae,Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources,Nanjing University of Chinese Medicine,Nanjing 210023,China)
出处
《药学学报》
CAS
CSCD
北大核心
2021年第4期895-905,共11页
Acta Pharmaceutica Sinica
基金
国家自然科学基金资助项目(81773983)
2020年江苏省大学生创新创业训练计划项目(154)。
关键词
肠道菌群
肝性脑病
治疗策略
发病机制
高氨血症
gut microbiota
hepatic encephalopathy
therapy
pathogenesis
hyperammonemia